- A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer2009 | Central Library of Charles University
- A Phase II Trial of Oral Vinorelbine and Capecitabine in Anthracycline Pretreated Patients with Metastatic Breast Cancer2009 | Central Library of Charles University
- A Phase II Trial of Oral Vinorelbine and Capecitabine in Anthracycline Pretreated Patients with Metastatic Breast Cancer2009 | First Faculty of Medicine
- A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer2009 | Faculty of Medicine in Pilsen
- A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer2009 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Oral vinorelbine in geriatric non-small cell lung cancer patientsPublication without faculty affiliation
- Phase II Study of a Triple Combination of Oral Vinorelbine, Capecitabine and Trastuzumab as First-line Treatment in HER2-positive Metastatic Breast Cancer2013 | First Faculty of Medicine
- Oral vinorelbine in elderly patients with advanced non-small cell lung cancerPublication without faculty affiliation
- Oral vinorelbine as adjuvant chemotherapy in non-small-cell lung cancer. A multicentre study of tolerability and feasibility2010 | Publication without faculty affiliation
- Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy2012 | Faculty of Medicine in Pilsen
- Chemotherapy with oral vinorelbine for geriatric patients with advanced non-small cell lung cancer-preliminary resultsPublication without faculty affiliation
- Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II study2004 | Third Faculty of Medicine
- First-line trastuzumab (H), oral vinorelbine (NVBo) and capecitabine (X) combination therapy for HER2-positive metastatic breast cancer (MBC): efficacy and safety in a multinational phase 2 studyPublication without faculty affiliation
- High efficacy of the combination chemotherapy (CT) of oral vinorelbine (NVBO) and capecitabine (X) with trastuzumab (H) in HER2-positive metastatic breast cancer (MBC): updated analysis of the results of an international phase 2 trialPublication without faculty affiliation
- Carboplatin with intravenous and subsequent oral administration of vinorelbine in resected non-small-cell-lung cancer in real-world set-up2017 | Publication without faculty affiliation
- Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer2009 | Third Faculty of Medicine
